Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
12.35
+0.37 (3.09%)
Apr 25, 2025, 1:42 PM EDT - Market open
Inhibrx Biosciences Analyst Ratings
Total Analysts
1
Consensus Rating
Hold
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 18, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 22, 2025 |
| JMP Securities | JMP Securities | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jul 23, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 23, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $27 | Buy | Reiterates | $27 | +118.62% | Nov 20, 2023 |
| JMP Securities | JMP Securities | Buy Maintains $35 → $27 | Buy | Maintains | $35 → $27 | +118.62% | Aug 23, 2023 |
| JMP Securities | JMP Securities | Buy Reiterates $35 | Buy | Reiterates | $35 | +183.40% | May 10, 2023 |
| JMP Securities | JMP Securities | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +183.40% | Mar 8, 2023 |
| Credit Suisse | Credit Suisse | Buy Reiterates $46 | Buy | Reiterates | $46 | +272.47% | Mar 7, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $48 → $46 | Buy | Maintains | $48 → $46 | +272.47% | Nov 8, 2022 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $54 → $60 | Buy | Maintains | $54 → $60 | +385.83% | Oct 5, 2022 |
| Credit Suisse | Credit Suisse | Buy Maintains $53 → $48 | Buy | Maintains | $53 → $48 | +288.66% | Aug 9, 2022 |
| SMBC Nikko | SMBC Nikko | Buy Initiates $40 | Buy | Initiates | $40 | +223.89% | Mar 16, 2022 |
| JMP Securities | JMP Securities | Buy Maintains $53 → $40 | Buy | Maintains | $53 → $40 | +223.89% | Mar 2, 2022 |
| Credit Suisse | Credit Suisse | Buy Maintains $44 → $53 | Buy | Maintains | $44 → $53 | +329.15% | Nov 10, 2021 |
| JMP Securities | JMP Securities | Buy Maintains $46 → $53 | Buy | Maintains | $46 → $53 | +329.15% | Nov 2, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.